ANVISA registration 10339840422Valid until Jun 27, 2036TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG)
ANVISA Registration Number: 10339840422DIASORIN LTDADIASORIN ITALIA S.P.A. UK BRANCHRisk Class IV
Device names
- Technical name
- TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG)
- Risk class
- Class IV
PT: ANTICORPO TOTAL NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBCAG)
Registration details
- Registration Number
- 10339840422
- Process Number
- 25351838968201625
- CNPJ
- 01896764000170
Company information
- Registration Holder
- DIASORIN LTDA
- Manufacturer
- DIASORIN ITALIA S.P.A. UK BRANCH
- Manufacturing Country
- United Kingdom
PT: REINO UNIDO
Dates and status
- Publication Date
- Jun 27, 2016
- Validity
- 27/06/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10339840422 and manufactured by DIASORIN ITALIA S.P.A. UK BRANCH. The registration is held by DIASORIN LTDA with validity until Jun 27, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.